BBIO
BridgeBio Pharma Inc
65.70$
-5.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -57.3% | +11,998.6% | -99.0% | +26.0% | +115.3% | +1,882.9% | -5.2% | +9.2% | +27.7% | +26.2% | +14.4% | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +248.5% | +26.6% | +38.4% | +79.7% | +134.9% | -32.4% | +44.3% | – | |
| – | -67.2% | +18,254.1% | -99.3% | +35.9% | +78.0% | +2,901.4% | -6.2% | +6.8% | +21.6% | +32.7% | +12.7% | – | |
| – | +4.1% | +8.3% | -18.6% | +5.0% | +8.2% | -14.5% | -0.2% | +1.5% | +25.8% | -10.8% | +18.0% | – | |
| – | +33.0% | +38.3% | -9.5% | +15.6% | +37.7% | +12.2% | +21.4% | +6.6% | +14.9% | +3.7% | +13.6% | – | |
| – | +10.8% | +17.7% | -15.7% | +9.5% | +18.5% | -5.0% | +10.5% | +7.5% | +24.9% | -10.5% | +8.4% | – | |
| – | – | – | -51,277.6% | – | – | – | – | – | – | – | – | – | |
| – | -0.2% | +15.8% | -2.3% | +0.5% | +29.3% | +41.3% | -10.7% | -68.8% | +2.2% | +340.1% | -74.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -105.1% | – | – | – | +89.6% | -3.9% | -173.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.